BENGALURU (Reuters) – India has approved emergency use of Biological E’s COVID-19 vaccine Corbevax for children aged five to 12 and Bharat Biotech’s Covaxin for six to 12-year olds, the country’s health minister said https://bit.ly/3OF11Ly in a tweet on Tuesday.
(Reporting by Rama Venkat in Bengaluru; Editing by Subhranshu Sahu)
